Japan: major biopharma companies by sales 2022

In fiscal year 2023, Mitsubishi Chemical Holdings emerged as the leading biopharmaceuticals-related company in Japan in terms of sales, with a reported revenue of approximately 4.6 trillion Japanese yen. Takeda Pharmaceutical was the second-biggest enterprise with around four trillion yen in sales.

Major biopharmaceuticals-related companies in Japan as of March 2022, by sales revenue (in billion Japanese yen)

Characteristic	Sales revenue in billion Japanese yen
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

January 2024

More information

Region

Japan

Survey time period

fiscal year 2022; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

figures for Suntory Holdings Ltd., Japan Tobacco Inc., and Asahi Group Holdings as of December 2022

Supplementary notes

100 Japanese yen equal 0.71 U.S. dollars or 0.64 euros as of January 2024.
Figures have been rounded.
The source did not provide a release date. Date given here is the access date.

Citation formats